Introducing Endovenous Laser Therapy Ablation to a National Health Service Vascular Surgical Unit

The Aberdeen Experience

R K MacKenzie, K Cassar, J Brittenden, P Bachoo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives
To report early clinical outcomes and learning experience following the introduction of endovenous laser ablation (EVLA) to an NHS vascular unit.

Design
Prospective observational study.

Results
Between February 2006 and January 2008, 631 consecutive patients underwent EVLA to 704 refluxing truncal veins – 579 GSV, 119 SSV and 6 straight segments of anterior accessory GSV. 275/631 (44%) patients had local anaesthesia (LA) plus sedation, 237 (38%) had LA only and 119 (18%) had general anaesthesia. All were treated using the 810 nm diode laser. Adjuvant procedures on-table included foam sclerotherapy 129/704 (18%), multiple stab avulsions 53/704 (8%) and 3 limbs had both. Three-month follow-up with duplex examination is complete in 635/704 limbs (90%). Complete occlusion was noted in 610 veins (96%), 14 (2.2%) were partially occluded and 11 (1.7%) showed no occlusion. 193 (30%) of the 635 limbs seen at follow-up required further treatment for residual varicosities using foam sclerotherapy. There has been one non-fatal pulmonary embolus associated with EVLA and no other complications.

Conclusions
EVLA is safe and technically effective. It has a defined learning curve requiring new operator skills which can be readily acquired.
Original languageEnglish
Pages (from-to)208-212
Number of pages5
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume38
Issue number2
Early online date22 May 2009
DOIs
Publication statusPublished - Aug 2009

Fingerprint

National Health Programs
Laser Therapy
Blood Vessels
Sclerotherapy
Extremities
Local Anesthesia
Veins
Semiconductor Lasers
Learning Curve
Embolism
General Anesthesia
Observational Studies
Learning
Lung
Therapeutics

Keywords

  • endovenous laser ablation
  • EVLA
  • varicose veins
  • national health service delivery

Cite this

Introducing Endovenous Laser Therapy Ablation to a National Health Service Vascular Surgical Unit : The Aberdeen Experience. / MacKenzie, R K; Cassar, K; Brittenden, J; Bachoo, P.

In: European Journal of Vascular and Endovascular Surgery, Vol. 38, No. 2, 08.2009, p. 208-212.

Research output: Contribution to journalArticle

@article{b5678b1437204d448b0ef13643a6928d,
title = "Introducing Endovenous Laser Therapy Ablation to a National Health Service Vascular Surgical Unit: The Aberdeen Experience",
abstract = "ObjectivesTo report early clinical outcomes and learning experience following the introduction of endovenous laser ablation (EVLA) to an NHS vascular unit.DesignProspective observational study.ResultsBetween February 2006 and January 2008, 631 consecutive patients underwent EVLA to 704 refluxing truncal veins – 579 GSV, 119 SSV and 6 straight segments of anterior accessory GSV. 275/631 (44{\%}) patients had local anaesthesia (LA) plus sedation, 237 (38{\%}) had LA only and 119 (18{\%}) had general anaesthesia. All were treated using the 810 nm diode laser. Adjuvant procedures on-table included foam sclerotherapy 129/704 (18{\%}), multiple stab avulsions 53/704 (8{\%}) and 3 limbs had both. Three-month follow-up with duplex examination is complete in 635/704 limbs (90{\%}). Complete occlusion was noted in 610 veins (96{\%}), 14 (2.2{\%}) were partially occluded and 11 (1.7{\%}) showed no occlusion. 193 (30{\%}) of the 635 limbs seen at follow-up required further treatment for residual varicosities using foam sclerotherapy. There has been one non-fatal pulmonary embolus associated with EVLA and no other complications.ConclusionsEVLA is safe and technically effective. It has a defined learning curve requiring new operator skills which can be readily acquired.",
keywords = "endovenous laser ablation, EVLA , varicose veins, national health service delivery",
author = "MacKenzie, {R K} and K Cassar and J Brittenden and P Bachoo",
year = "2009",
month = "8",
doi = "10.1016/j.ejvs.2009.03.032",
language = "English",
volume = "38",
pages = "208--212",
journal = "European Journal of Vascular and Endovascular Surgery",
issn = "1078-5884",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Introducing Endovenous Laser Therapy Ablation to a National Health Service Vascular Surgical Unit

T2 - The Aberdeen Experience

AU - MacKenzie, R K

AU - Cassar, K

AU - Brittenden, J

AU - Bachoo, P

PY - 2009/8

Y1 - 2009/8

N2 - ObjectivesTo report early clinical outcomes and learning experience following the introduction of endovenous laser ablation (EVLA) to an NHS vascular unit.DesignProspective observational study.ResultsBetween February 2006 and January 2008, 631 consecutive patients underwent EVLA to 704 refluxing truncal veins – 579 GSV, 119 SSV and 6 straight segments of anterior accessory GSV. 275/631 (44%) patients had local anaesthesia (LA) plus sedation, 237 (38%) had LA only and 119 (18%) had general anaesthesia. All were treated using the 810 nm diode laser. Adjuvant procedures on-table included foam sclerotherapy 129/704 (18%), multiple stab avulsions 53/704 (8%) and 3 limbs had both. Three-month follow-up with duplex examination is complete in 635/704 limbs (90%). Complete occlusion was noted in 610 veins (96%), 14 (2.2%) were partially occluded and 11 (1.7%) showed no occlusion. 193 (30%) of the 635 limbs seen at follow-up required further treatment for residual varicosities using foam sclerotherapy. There has been one non-fatal pulmonary embolus associated with EVLA and no other complications.ConclusionsEVLA is safe and technically effective. It has a defined learning curve requiring new operator skills which can be readily acquired.

AB - ObjectivesTo report early clinical outcomes and learning experience following the introduction of endovenous laser ablation (EVLA) to an NHS vascular unit.DesignProspective observational study.ResultsBetween February 2006 and January 2008, 631 consecutive patients underwent EVLA to 704 refluxing truncal veins – 579 GSV, 119 SSV and 6 straight segments of anterior accessory GSV. 275/631 (44%) patients had local anaesthesia (LA) plus sedation, 237 (38%) had LA only and 119 (18%) had general anaesthesia. All were treated using the 810 nm diode laser. Adjuvant procedures on-table included foam sclerotherapy 129/704 (18%), multiple stab avulsions 53/704 (8%) and 3 limbs had both. Three-month follow-up with duplex examination is complete in 635/704 limbs (90%). Complete occlusion was noted in 610 veins (96%), 14 (2.2%) were partially occluded and 11 (1.7%) showed no occlusion. 193 (30%) of the 635 limbs seen at follow-up required further treatment for residual varicosities using foam sclerotherapy. There has been one non-fatal pulmonary embolus associated with EVLA and no other complications.ConclusionsEVLA is safe and technically effective. It has a defined learning curve requiring new operator skills which can be readily acquired.

KW - endovenous laser ablation

KW - EVLA

KW - varicose veins

KW - national health service delivery

U2 - 10.1016/j.ejvs.2009.03.032

DO - 10.1016/j.ejvs.2009.03.032

M3 - Article

VL - 38

SP - 208

EP - 212

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

SN - 1078-5884

IS - 2

ER -